Written answers
Tuesday, 19 February 2019
Department of Health
Medicinal Products Regulation
John Brassil (Kerry, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
321. To ask the Minister for Health the findings of research undertaken by the National Centre for Pharmacoeconomics into the potential effect of broadening the health technology criteria for assessing orphan drugs; and if he will make a statement on the matter. [7690/19]
Simon Harris (Wicklow, Fine Gael)
Link to this: Individually | In context | Oireachtas source
I am advised by the National Centre for Pharmacoeconomics (NCPE) that it periodically conducts and publishes peer reviewed research in the area of Health Technology Assessments. This research is to ensure that the methods used are robust and are in line with best practice. More recent research has examined the methods used for orphan drug evaluation and tested a number of measures that have been used in other countries for evaluation of this group of technologies.
The NCPE has advised that the research is due for publication later this year and that it would be happy to share the findings once published.
No comments